154 related articles for article (PubMed ID: 26947932)
1. RUNX1 amplification in AML with myelodysplasia-related changes and ring 21 chromosomes.
Burillo-Sanz S; Vargas MT; Morales-Camacho RM; Caballero-Velázquez T; Sánchez J; García-Lozano JR; Pérez de Soto I; Prats-Martín C; Bernal R; Pérez-Simón JA
Hematol Oncol; 2017 Dec; 35(4):894-899. PubMed ID: 26947932
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterisation of a recurrent, semi-cryptic RUNX1 translocation t(7;21) in myelodysplastic syndrome and acute myeloid leukaemia.
Foster N; Paulsson K; Sales M; Cunningham J; Groves M; O'Connor N; Begum S; Stubbs T; McMullan DJ; Griffiths M; Pratt N; Tauro S
Br J Haematol; 2010 Mar; 148(6):938-43. PubMed ID: 20064152
[TBL] [Abstract][Full Text] [Related]
3. IS THE AMPLIFICATION OF c-MYC, MLL AND RUNX1 GENES IN AML AND MDS PATIENTS WITH TRISOMY 8, 11 AND 21 A FACTOR FOR A CLONAL EVOLUTION IN THEIR KARYOTYPE?
Angelova S; Spassov B; Nikolova V; Christov I; Tzvetkov N; Simeonova M
Tsitol Genet; 2015; 49(3):25-32. PubMed ID: 26214902
[TBL] [Abstract][Full Text] [Related]
4. Amplification of the AML1(CBFA2) gene on ring chromosomes in a patient with acute myeloid leukemia and a constitutional ring chromosome 21.
Streubel B; Valent P; Lechner K; Fonatsch C
Cancer Genet Cytogenet; 2001 Jan; 124(1):42-6. PubMed ID: 11165321
[TBL] [Abstract][Full Text] [Related]
5. Marker chromosomes are a significant mechanism of high-level RUNX1 gene amplification in hematologic malignancies.
Moosavi SA; Sanchez J; Adeyinka A
Cancer Genet Cytogenet; 2009 Feb; 189(1):24-8. PubMed ID: 19167608
[TBL] [Abstract][Full Text] [Related]
6. Familial myelodysplasia and acute myeloid leukaemia--a review.
Owen C; Barnett M; Fitzgibbon J
Br J Haematol; 2008 Jan; 140(2):123-32. PubMed ID: 18173751
[TBL] [Abstract][Full Text] [Related]
7. Amplification of the MLL gene on double minutes, a homogeneously staining region, and ring chromosomes in five patients with acute myeloid leukemia or myelodysplastic syndrome.
Streubel B; Valent P; Jäger U; Edelhäuser M; Wandt H; Wagner T; Büchner T; Lechner K; Fonatsch C
Genes Chromosomes Cancer; 2000 Apr; 27(4):380-6. PubMed ID: 10719368
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms that produce secondary MDS/AML by RUNX1/AML1 point mutations.
Harada Y; Harada H
J Cell Biochem; 2011 Feb; 112(2):425-32. PubMed ID: 21268063
[TBL] [Abstract][Full Text] [Related]
9. miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia.
Fischer J; Rossetti S; Datta A; Eng K; Beghini A; Sacchi N
Mol Cancer; 2015 Jan; 14():7. PubMed ID: 25612891
[TBL] [Abstract][Full Text] [Related]
10. RUNX1 upregulation via disruption of long-range transcriptional control by a novel t(5;21)(q13;q22) translocation in acute myeloid leukemia.
Cheng CK; Wong THY; Wan TSK; Wang AZ; Chan NPH; Chan NCN; Li CK; Ng MHL
Mol Cancer; 2018 Aug; 17(1):133. PubMed ID: 30157851
[TBL] [Abstract][Full Text] [Related]
11. Two novel translocations disrupt the RUNX1 gene in acute myeloid leukemia.
Dai H; Xue Y; Pan J; Wu Y; Wang Y; Shen J; Zhang J
Cancer Genet Cytogenet; 2007 Sep; 177(2):120-4. PubMed ID: 17854666
[TBL] [Abstract][Full Text] [Related]
12. A novel case of intrachromosomal amplification and insertion of RUNX1 on derivative chromosome 2 in pediatric AML.
Jain H; Shetty D; Roy Moulik N; Narula G; Subramanian PG; Banavali S
Cancer Genet; 2021 Jun; 254-255():65-69. PubMed ID: 33647813
[TBL] [Abstract][Full Text] [Related]
13. AML1/RUNX1 gene point mutations in childhood myeloid malignancies.
Migas A; Savva N; Mishkova O; Aleinikova OV
Pediatr Blood Cancer; 2011 Oct; 57(4):583-7. PubMed ID: 21294243
[TBL] [Abstract][Full Text] [Related]
14. RUNX1 deletion/amplification in therapy-related acute myeloid leukemia: A case report and review of the literature.
Nguyen D; Li Y; Safah H; Brown TC
Cancer Genet; 2019 Oct; 238():37-43. PubMed ID: 31425924
[TBL] [Abstract][Full Text] [Related]
15. Gain of chromosome 21 or amplification of chromosome arm 21q is one mechanism for increased ERG expression in acute myeloid leukemia.
Weber S; Haferlach C; Jeromin S; Nadarajah N; Dicker F; Noël L; Zenger M; Alpermann T; Kern W; Haferlach T; Schnittger S
Genes Chromosomes Cancer; 2016 Feb; 55(2):148-57. PubMed ID: 26542308
[TBL] [Abstract][Full Text] [Related]
16. Constitutional RUNX1 deletion presenting as non-syndromic thrombocytopenia with myelodysplasia: 21q22 ITSN1 as a candidate gene in mental retardation.
van der Crabben S; van Binsbergen E; Ausems M; Poot M; Bierings M; Buijs A
Leuk Res; 2010 Jan; 34(1):e8-12. PubMed ID: 19679353
[No Abstract] [Full Text] [Related]
17. Fanconi Anemia patient with AML1 gene amplification and monosomy 7 in pre-transplant myelodysplasia (MDS) relapsing 7 years after successful allo-SCT.
Ayas M; Walter C
Bone Marrow Transplant; 2008 Oct; 42(8):555-7. PubMed ID: 18622412
[No Abstract] [Full Text] [Related]
18. Amplification or duplication of chromosome band 21q22 with multiple copies of the AML1 gene and mutation of the TP53 gene in therapy-related MDS and AML.
Andersen MK; Christiansen DH; Pedersen-Bjergaard J
Leukemia; 2005 Feb; 19(2):197-200. PubMed ID: 15618958
[TBL] [Abstract][Full Text] [Related]
19. Isodicentric/pseudoisodicentric chromosome 21 amplification in four cases of acute myelocytic leukemia or myelodysplasia.
Viguié F; Aboura A; Bouscary D; Guesnu M; Baumelou E; Dreyfus F; Casadevall N; Tachdjian G
Cancer Genet Cytogenet; 2002 Oct; 138(1):80-4. PubMed ID: 12419591
[TBL] [Abstract][Full Text] [Related]
20. Comparison of mutational profiles and clinical outcomes in patients with acute myeloid leukemia with mutated
Nguyen L; Zhang X; Roberts E; Yun S; McGraw K; Abraham I; Song J; Braswell D; Qin D; Sallman DA; Lancet JE; List AF; Moscinski LC; Padron E; Zhang L
Leuk Lymphoma; 2020 Jun; 61(6):1395-1405. PubMed ID: 32091281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
